Clinical trials timelines always seem to expand.
I was pleased to see our phase 2 started this quarter like they said it would.
And yes, good results could see this being approved before the phase 3. The big stumbling block there is normally safety, but that appears to be our trump card (in the none Donald sense).
- Forums
- ASX - By Stock
- Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
Clinical trials timelines always seem to expand. I was pleased...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1050000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 134148 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5665336 | 0.018 |
14 | 3997559 | 0.017 |
6 | 2974375 | 0.016 |
10 | 3219799 | 0.015 |
4 | 497500 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 2 |
0.020 | 5410946 | 12 |
0.021 | 8494780 | 17 |
0.022 | 8757253 | 13 |
0.023 | 4826614 | 8 |
Last trade - 09.13am 26/11/2024 (20 minute delay) ? |
IMU (ASX) Chart |
Day chart unavailable